Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2001 Jan;51(1):13-25.
doi: 10.1046/j.1365-2125.2001.01294.x.

Drug treatment of obesity: from past failures to future successes?

Affiliations
Review

Drug treatment of obesity: from past failures to future successes?

P Collins et al. Br J Clin Pharmacol. 2001 Jan.
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
Diagrammatic representation of the effects of leptin in energy homeostasis.
Figure 2
Figure 2
Hypothetical dose-response curves for the anti-obesity action of leptin. In both men and rodents, the total absence of leptin causes hyperphagia and early-onset morbid obesity, proving that leptin is involved in regulating energy balance. In rodents, food intake and body weight fall as plasma leptin levels are increased through the physiological and into the pharmacological range. The shape of the dose-response curve in man is unknown, but leptin levels in the physiological and pharmacological range do not appear to decrease fat mass as powerfully as in rodents. This blunting of leptin action could be due to physiological ‘leptin resistance’ or the overwhelming effect of psychosocial factors in human eating behaviour.
Figure 3
Figure 3
Diagram showing binding of [125I]NDP-MSH in the rat hypothalamus. Binding is most intense at the hypothalamic ventromedial (VMH) and arcuate nuclei (ARC) and the median eminence (ME). With lower levels in the medial habenulla (MHb) These areas are known to be important in the control of food intake.
Figure 4
Figure 4
Immunohistochemical labelling (blue staining) of Orexin-A (upper panel) and MCH (lower panel) in the hypothalamus of rats made hypoglycaemic with insulin. 3V=3rd ventricle; f=fornix; mt=mammillothalamic tract.

Similar articles

  • The future of leptin and leptin analogues in the treatment of obesity.
    Bryson JM. Bryson JM. Diabetes Obes Metab. 2000 Apr;2(2):83-9. doi: 10.1046/j.1463-1326.2000.00052.x. Diabetes Obes Metab. 2000. PMID: 11220528 Review. No abstract available.
  • Science, medicine, and the future. Obesity treatment.
    Wilding J. Wilding J. BMJ. 1997 Oct 18;315(7114):997-1000. doi: 10.1136/bmj.315.7114.997. BMJ. 1997. PMID: 9365300 Free PMC article. Review. No abstract available.
  • Obesity.
    Yanovski SZ, Yanovski JA. Yanovski SZ, et al. N Engl J Med. 2002 Feb 21;346(8):591-602. doi: 10.1056/NEJMra012586. N Engl J Med. 2002. PMID: 11856799 Review. No abstract available.
  • Drug treatments for obesity.
    Couzigou P. Couzigou P. Lancet. 2007 Apr 7;369(9568):1163-4; author reply 1164. doi: 10.1016/S0140-6736(07)60553-4. Lancet. 2007. PMID: 17416249 No abstract available.
  • [The pharmacotherapy of obesity].
    Budai KA, Mirzahosseini A, Noszál Béla, Tóth G. Budai KA, et al. Acta Pharm Hung. 2015;85(1):3-17. Acta Pharm Hung. 2015. PMID: 26137782 Review. Hungarian.

Cited by

References

    1. Seidell JC, Flegal KM. Assessing obesity: classification and epidemiology. Br Med Bull. 1997;53:13–25. - PubMed
    1. Wolf AM, Golditz GA. The Cost of Obesity. The US Perspective Pharmacoeconomics. 1994;5:34–37. - PubMed
    1. Prentice AM, Jebb SA. Obesity in Britain: gluttony or sloth? [see comments] Br Med J. 1995;311:437–439. - PMC - PubMed
    1. Prentice AM, Black AE, Coward WA, et al. High levels of energy expenditure in obese women. Br Med J. 1986;292:983–987. - PMC - PubMed
    1. Allison DB, Kaprio J, Korkeila M, Koskenvuo M, Neale MC, Hayakawa K. The heritability of body mass index among an international sample of monozygotic twins reared apart. Int J Obes Relat Metab Disord. 1996;20:501–506. - PubMed

Substances